
Avacopan Safety Described in Pooled Vasculitis Trial Data
TOPLINE: Avacopan treatment for antineutrophil cytoplasmic antibody–associated vasculitis demonstrated lower rates of adverse events, serious adverse events, white blood cell (WBC) count reductions, and infections than standard treatment without avacopan. …